RESUMO
This paper presents a simple, cost-efficient, and highly stable quantitative differential phase-contrast (PC) microscopy based on Talbot interferometry. The proposed system is composed of an optical microscope coupled with a pair of Ronchi amplitude gratings that utilizes a light-emitting diode as a low temporal coherence light source. The quantitative differential PC images of the microscopic transparent samples are reconstructed by analyzing the deformation of moiré patterns using a phase-shifting procedure. Low temporal coherence leads to eliminating speckle noise and undesirable interferences to obtain high-quality images. The spatial phase stability of the system is investigated and compared to two other common-path interferometers. Additionally, the performance of the method is verified by the experimental results of a standard resolution test target and phase biological samples.
RESUMO
Histological analysis is the core of follicular thyroid carcinoma (FTC) classification. The histopathological criteria of capsular and vascular invasion define malignancy and aggressiveness of FTC. Analysis of multiple sections is cumbersome and as only a minute tissue fraction is analyzed during histopathology, under-sampling remains a problem. Application of an efficient tool for complete tissue imaging in 3D would speed-up diagnosis and increase accuracy. We show that X-ray propagation-based imaging (XPBI) of paraffin-embedded tissue blocks is a valuable complementary method for follicular thyroid carcinoma diagnosis and assessment. It enables a fast, non-destructive and accurate 3D virtual histology of the FTC resection specimen. We demonstrate that XPBI virtual slices can reliably evaluate capsular invasions. Then we discuss the accessible morphological information from XPBI and their significance for vascular invasion diagnosis. We show 3D morphological information that allow to discern vascular invasions. The results are validated by comparing XPBI images with clinically accepted histology slides revised by and under supervision of two experienced endocrine pathologists.